STOCK TITAN
  1. Home
  2. Sec-filings
  3. ADIL
  4. [EFFECT] ADIAL PHARMACEUTICALS, INC. SEC Filing

[EFFECT] ADIAL PHARMACEUTICALS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 17, 2025 4:00 P.M.
Form: S-3
CIK: 0001513525
Company Name: ADIAL PHARMACEUTICALS, INC.
File Number: 333-292110

Source: View Original Filing on SEC EDGAR

Stock ADIL logo
Adial Pharmaceuticals Inc

NASDAQ:ADIL

ADIL Rankings

#6984 Ranked by Market Cap
N/A Ranked by Dividends

ADIL Latest News

Feb 4, 2026
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04
Feb 3, 2026
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
Jan 14, 2026
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045
Nov 26, 2025
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds
Nov 14, 2025
Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

ADIL Latest SEC Filings

Feb 4, 2026
[8-K] ADIAL PHARMACEUTICALS, INC. Reports Material Event
Jan 6, 2026
[DEF 14A] ADIAL PHARMACEUTICALS, INC. Definitive Proxy Statement
Jan 6, 2026
[8-K] ADIAL PHARMACEUTICALS, INC. Reports Material Event
Dec 12, 2025
[S-3] ADIAL PHARMACEUTICALS, INC. Shelf Registration Statement
Nov 14, 2025
[8-K] ADIAL PHARMACEUTICALS, INC. Reports Material Event

ADIL Stock Data

152.23k
1.08M
2.47%
2.62%
6.55%
Biotechnology
Pharmaceutical Preparations
Link
United States
CHARLOTTESVILLE